Latest Insider Transactions at Venus Concept Inc. (VERO)
This section provides a real-time view of insider transactions for Venus Concept Inc. (VERO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Venus Concept Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Venus Concept Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 03
2024
|
Michael Willingham Masters > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
162,896
-21.79%
|
$0
$0.53 P/Share
|
|
Oct 02
2024
|
Michael Willingham Masters > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
94,553
-11.23%
|
$0
$0.53 P/Share
|
|
Oct 01
2024
|
Michael Willingham Masters > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
140,214
-14.27%
|
$0
$0.6 P/Share
|
|
Sep 30
2024
|
Michael Willingham Masters > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
71,368
-6.77%
|
$0
$0.64 P/Share
|
|
Jun 11
2024
|
Michael Willingham Masters > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
102,717
-21.13%
|
$102,717
$1.2 P/Share
|
|
Jun 11
2024
|
Michael Willingham Masters > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
233,345
+32.44%
|
-
|
|
Jun 10
2024
|
Michael Willingham Masters > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
666,702
+50.0%
|
-
|
|
Jun 07
2024
|
Michael Willingham Masters > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
387,231
-86.26%
|
$387,231
$1.2 P/Share
|
|
Aug 11
2023
|
Michael Mandarello General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
233
-13.52%
|
-
|
|
Aug 11
2023
|
Michael Mandarello General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
834
+32.6%
|
-
|
|
Mar 25
2023
|
Michael Mandarello General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
5,409
-28.85%
|
-
|
|
Mar 25
2023
|
Michael Mandarello General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
18,750
+50.0%
|
-
|
|
Mar 25
2023
|
Domenic Della Penna Exec VP & General Manager |
SELL
Payment of exercise price or tax liability
|
Direct |
12,778
-7.78%
|
-
|
|
Mar 25
2023
|
Domenic Della Penna Exec VP & General Manager |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+18.6%
|
-
|
|
Mar 25
2023
|
Anna Georgiadis Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,873
-31.32%
|
-
|
|
Mar 25
2023
|
Anna Georgiadis Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,750
+50.0%
|
-
|
|
Mar 25
2023
|
William H Mcgrail Sr. VP |
SELL
Payment of exercise price or tax liability
|
Direct |
4,717
-37.74%
|
-
|
|
Mar 25
2023
|
William H Mcgrail Sr. VP |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+50.0%
|
-
|
|
Mar 25
2023
|
Ross Portaro Exec VP & General Manager |
SELL
Payment of exercise price or tax liability
|
Direct |
11,034
-7.61%
|
-
|
|
Mar 25
2023
|
Ross Portaro Exec VP & General Manager |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+14.71%
|
-
|
|
Nov 29
2022
|
Anthony Natale Director |
SELL
Open market or private sale
|
Indirect |
51,431
-7.42%
|
$0
$0.24 P/Share
|
|
Nov 28
2022
|
Anthony Natale Director |
SELL
Open market or private sale
|
Indirect |
51,428
-6.91%
|
$0
$0.27 P/Share
|
|
Nov 25
2022
|
Anthony Natale Director |
SELL
Open market or private sale
|
Indirect |
51,428
-6.46%
|
$0
$0.31 P/Share
|
|
Nov 23
2022
|
Anthony Natale Director |
SELL
Open market or private sale
|
Indirect |
51,428
-6.07%
|
$0
$0.33 P/Share
|
|
Nov 22
2022
|
Anthony Natale Director |
SELL
Open market or private sale
|
Indirect |
51,428
-5.72%
|
$0
$0.2 P/Share
|
|
Nov 21
2022
|
Ross Portaro Exec VP & General Manager |
BUY
Open market or private purchase
|
Direct |
60,000
+33.33%
|
$0
$0.22 P/Share
|
|
Nov 18
2022
|
Rajiv De Silva Officer |
BUY
Open market or private purchase
|
Direct |
1,250,000
+50.0%
|
$0
$0.2 P/Share
|
|
Nov 18
2022
|
Hemanth Jacob Varghese President/Chief Bus. Officer |
BUY
Open market or private purchase
|
Direct |
250,000
+50.0%
|
$0
$0.2 P/Share
|
|
Nov 18
2022
|
Stanley Tyler Hollmig Director |
BUY
Open market or private purchase
|
Direct |
250,000
+46.3%
|
$0
$0.2 P/Share
|
|
Sep 16
2022
|
Domenic Della Penna Exec VP & General Manager |
BUY
Open market or private purchase
|
Direct |
60,000
+21.42%
|
$0
$0.59 P/Share
|
|
Sep 12
2022
|
Anna Georgiadis Chief HR Officer |
BUY
Open market or private purchase
|
Indirect |
12,782
+50.0%
|
$0
$0.71 P/Share
|
|
Aug 31
2022
|
Domenic Serafino Former Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
37,500
+3.58%
|
$0
$0.33 P/Share
|
|
Aug 30
2022
|
Domenic Serafino Former Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
37,500
+3.72%
|
$0
$0.34 P/Share
|
|
May 24
2022
|
Stanley Tyler Hollmig Director |
BUY
Open market or private purchase
|
Direct |
40,000
+50.0%
|
$0
$0.64 P/Share
|
|
May 20
2022
|
Domenic Serafino Former Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
65,000
+6.51%
|
$0
$0.75 P/Share
|
|
May 17
2022
|
Ross Portaro Exec VP & General Manager |
BUY
Open market or private purchase
|
Direct |
10,000
+14.29%
|
$0
$0.85 P/Share
|
|
Dec 16
2021
|
Ross Portaro Exec VP & General Manager |
BUY
Open market or private purchase
|
Direct |
20,000
+28.57%
|
$20,000
$1.35 P/Share
|
|
Dec 15
2021
|
Garheng Kong Director |
BUY
Open market or private purchase
|
Indirect |
1,600,000
+19.06%
|
$1,600,000
$1.25 P/Share
|
|
Dec 15
2021
|
Keith J Sullivan Director |
BUY
Open market or private purchase
|
Indirect |
80,000
+50.0%
|
$80,000
$1.25 P/Share
|
|
Dec 15
2021
|
Health Quest Partners Ii, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,600,000
+19.06%
|
$1,600,000
$1.25 P/Share
|
|
Dec 15
2021
|
Richard Scott Barry Director |
BUY
Open market or private purchase
|
Indirect |
3,920,000
+10.13%
|
$3,920,000
$1.25 P/Share
|
|
Dec 15
2021
|
Ew Healthcare Partners, L.P. |
BUY
Open market or private purchase
|
Indirect |
151,612
+0.92%
|
$151,612
$1.25 P/Share
|
|
Dec 15
2021
|
Ew Healthcare Partners, L.P. |
BUY
Open market or private purchase
|
Direct |
3,768,388
+19.35%
|
$3,768,388
$1.25 P/Share
|
|
Dec 03
2021
|
Ross Portaro Exec VP & General Manager |
BUY
Open market or private purchase
|
Direct |
30,000
+50.0%
|
$30,000
$1.35 P/Share
|
|
Dec 01
2021
|
Domenic Serafino Former Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
37,500
+4.14%
|
$37,500
$1.32 P/Share
|
|
Nov 19
2021
|
Domenic Serafino Former Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
17,000
+2.0%
|
$17,000
$1.48 P/Share
|
|
Nov 17
2021
|
Domenic Serafino Former Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
15,500
+1.87%
|
$15,500
$1.6 P/Share
|
|
Aug 18
2021
|
Yoni Iger VP, RA/QA/Clinical Affairs |
BUY
Open market or private purchase
|
Direct |
5,181
+50.0%
|
$5,181
$1.94 P/Share
|
|
Jul 12
2021
|
Sedco Capital Cayman LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
50,000
-2.6%
|
$150,000
$3.25 P/Share
|
|
Jul 09
2021
|
Sedco Capital Cayman LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
57,933
-2.83%
|
$173,799
$3.28 P/Share
|